Induction of the differentiation of cultured endometrial carcinoma cells by type I collagen: Relevance of sulfolipids

Hopfer H, Rinehart CA, Kaufman DG and Vollmer G: Basement membrane induced differentiation of HEC-1B(L) endometrial adenocarcinoma cells affect both morphology and gene expression. Biochem Cell Biol. 74:165–177. 1996. View Article : Google Scholar

Kubushiro K, Kojima K, Mikami M, Nozawa S, Iizuka R, Iwamori M and Nagai Y: Menstrual cycle-associated alteration of sulfogalactosylceramide in human uterine endometrium. Arch Biochem Biophys. 268:129–136. 1989. View Article : Google Scholar : PubMed/NCBI

Kiguchi K, Takamastu K, Tanaka J, Nozawa S, Iwamori M and Nagai Y: Glycosphingoplipids of various human ovarian tumors: a significantly high expression of I³SO₃ GalCer and Lewis antigen in mucinous cyst adenocarcinoma. Cancer Res. 52:416–421. 1992.PubMed/NCBI

Kubushiro K, Tsukazaki K, Tanaka J, Takamastu K, Kuguchi K, Mikami M, Nozawa S, Nagai Y and Iwamori M: Human uterine endometrial adenocarcinoma: characteristic acquirement of synthetic potentials for II³SO₃-LacCer and Ganglio series sulfoglycosphingolipids after transfer of the cancer cells to culture. Cancer Res. 52:803–809. 1992.

Nozawa S, Sakayori M, Ohta K, Iizuka R, Mochizuki H, Soma M, Fujimoto J, Hata J, Iwamori M and Nagai Y: A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell lines (SNG-II) and its application to immunohistochemıstry and flow cytometry. Am J Obstet Gynecol. 161:1079–1086. 1989.PubMed/NCBI

Ishiwata I, Nozawa S, Inoue T and Okumura H: Development and characterization of established cell lines from primary and metastatic region of human endometrial adenocarcinoma. Cancer Res. 37:1777–1785. 1977.PubMed/NCBI

Nishida M, Kasahara K, Kaneko K, Iwasaki H and Hayashi K: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynecol Jpn. 37:1103–1111. 1985.

Morizawa T: Establishment and characterization of a endometrial cancer cell line. J Jpn Soc Clin Cytol. 26:433–442. 1987. View Article : Google Scholar

Shimizu H, Inoue M and Tanizawa O: Adoptive cellular immunotherapy to the endometrial cancer cell line xenografts in nude mice. Gynecol Oncol. 34:195–199. 1989. View Article : Google Scholar : PubMed/NCBI

Behrens P, Meissner C, Hopfer H, Schümann J, Tan MI, Ellerbrake N, Strunck E and Vollmer G: Laminin mediates basement membrane induced differrentiation of HEC 1B endometrial adenocarcinoma cells. Biochem Cell Biol. 74:875–886. 1996. View Article : Google Scholar : PubMed/NCBI

Taraboletti G, Rao CN, Krutzsch HC, Liotta LA and Roberts DD: Sulfatide-binding domain of the laminin A chain. J Biol Chem. 265:12253–12258. 1990.PubMed/NCBI

Kawakita M, Tsuji Y, Nakata Y, Ogasawara T, Takemura T, Isojima S and Koyama K: Progesterone treatment decreases sulfate carbohydrate antigen on endometrial carcinoma cells and inhibits the cell binding to laminin. Gynecol Oncol. 57:313–320. 1995. View Article : Google Scholar

Kuroki T, Ikuta T, Kashiwagi M, Kawabe S, Ohba M, Huh N, Mizuno K, Ohno S, Yamada E and Chida K: Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a review. Mutat Res. 462:189–195. 2000. View Article : Google Scholar : PubMed/NCBI

Kashiwagi M, Ohba M, Chida K and Kuroki T: Protein kinase C eta (PKC eta): its involvement in keratinocyte differentiation. J Biochem. 132:853–857. 2002. View Article : Google Scholar : PubMed/NCBI